Navigation Links
Kaixin Jieyu Fang for treatment of vascular depression

The Chinese compound Kaixin Jieyu Fang can be used to treat vascular depression; however, the underlying mechanism remains unclear. Dr. Ying Zhang and co-workers from Guang'anmen Hospital, China Academy of Chinese Medical Sciences in China This study established a rat model of chronic cerebral ischemia-caused white matter damage by ligation of the bilateral common carotid arteries. Rats received daily intragastric administration of a suspension of Kaixin Jieyu Fang powder. Kaixin Jieyu Fang was made from two prescriptions of Kaixin San and Sini San supplemented with Radix Morindae Offcinalis, consisting of eight Chinese herbs including Radix Ginseng, Radix Bupleuri, Fructus Aurantii Immaturus, Radix Morindae Officinalis, Poria, Radix Polygalae, Radix Paeoniae Rubra and Radix Glycytthizae. After treatment, the degree of white matter damage in the cerebral ischemia rat model was alleviated, Bcl-2 protein and mRNA expression in brain tissue increased, and Bax protein and mRNA expression decreased. These results, published in the Neural Regeneration Research (Vol. 9, No. 1, 2014), indicate that Kaixin Jieyu Fang can alleviate cerebral white matter damage, and the underlying mechanism is associated with regulation of Bcl-2/Bax protein and mRNA expression, which is one of possible mechanism behind the protective effect of Kaixin Jieyu Fang against vascular depression.


Contact: Meng Zhao
Neural Regeneration Research

Page: 1

Related medicine news :

1. Treatment helps reduce risk of esophagus disorder progressing to cancer
2. Researchers issue state-of-the-state on genetic-based testing and treatment for breast cancer
3. Twenty-five percent of breast cancer survivors report financial decline due to treatment
4. Einstein helps establish $28 million consortium to find ebola treatment
5. Chemo-free treatment a possibility for leukemia/lymphoma
6. Sepsis study comparing 3 treatment methods shows same survival rate
7. Dartmouth researchers develop new approach to chronic lymphocytic leukemia treatment
8. Gene variants protect against relapse after treatment for hepatitis C
9. PSA-testing and early treatment decreases risk of prostate cancer death
10. Emerging multi-drug resistant infections lack standard definition and treatment
11. Making treatment of rare blood disorder more affordable and effective
Post Your Comments:
Related Image:
Kaixin Jieyu Fang for treatment of vascular depression
(Date:11/24/2015)... New Port Richey, FL (PRWEB) , ... November 24, 2015 , ... ... what it deems a growing epidemic as deaths from prescription opioids in the United ... from heroin and cocaine. In 2013 alone, opioids were involved in 37 percent of ...
(Date:11/24/2015)... ... ... American Family Care (AFC), the nation’s leading provider of urgent care and accessible ... Atlanta’s North Point Mall. The clinic is designed to test the concept of addressing ... operate through Dec. 24. , Holiday Pop-Up Clinic , Official Opening November 27, 6 ...
(Date:11/24/2015)... CA (PRWEB) , ... November 24, 2015 , ... Cold Shoulder , LLC launched ... Kickstarter last week and hit their goal of $20,000 in under 10 hours. ... aims to bring the new PRO Weight Loss Vest to the market. , The PRO ...
(Date:11/24/2015)... ... November 24, 2015 , ... Sir ... customer service: the TrustDale certification. The award recognizes good companies for excellence in ... , tile and grout, and hard surface restoration company earned this recognition after ...
(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Kevin Day, local family chiropractor in ... less this holiday season. During the Indiana winter months, Vitamin D deficiency can ... team at AlignLife want to help provide the tools needed to combat it this ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)...  NuShield, Inc., an industry leader in LCD screen protection and glare-elimination technology, is providing a ... of their patient monitoring or electronic documentation system. ... ... ... A study in 2013 by the National ...
(Date:11/24/2015)... 24, 2015 Abaxis, Inc. (NasdaqGS: ABAX ... consumables for the medical, research, and veterinary markets worldwide, ... Officer, will present at the 27 th Annual ... at 11:30 a.m. ET. The conference will be held ... New York City . Abaxis, Inc. ...
(Date:11/24/2015)... Nov. 24, 2015  Wellness Center USA , Inc. ... its flagship product, Psoria-Light® (PL 1000), to targeted dermatology markets in ... Minnesota , and North Carolina . This follows ... , Chicago , and New York ... Revenue for the earlier shipments reported on October 1, 2015 will ...
Breaking Medicine Technology: